Media store

Media Releases

Basel, 18 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that unfortunately it will not be possible for shareholders to attend the Annual General Meeting in person owing to the ...

Published on: 12 January 2021

Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

Basel, 12 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed that the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase additional ...

Published on: 12 January 2021

Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer

Basel, 12 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present updated overall survival (OS) data from the Phase III IMbrave150 study evaluating Tecentriq® (atezolizumab) in combination ...

Upcoming Events

All

4February

Roche Full Year Results 2020

(GMT)

London, UK

add to calendar

21April

Roche 1st Quarter Sales 2021

(CEST)

Basel

add to calendar

22July

Roche Half Year Results 2021

(CEST)

Basel

add to calendar

20October

Roche 3rd Quarter Sales 2021

(CEST)

Basel

add to calendar

Media contacts

For media requests

+41 61 688 8888

Media Relations Team

For all general enquiries

Please call the Roche switchboard on
Phone:+41 61 688 11 11

Media store

Roche Annual General Meeting 2021: Exercising of shareholder rights via the independent proxy

Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer

Roche Full Year Results 2020

Roche 1st Quarter Sales 2021

Roche Half Year Results 2021

Roche 3rd Quarter Sales 2021

Media contacts

For media requests

For all general enquiries